PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pemphigus Vulgaris

Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris

Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris

October 14, 2019

Genentech Reports Positive Results of Rituxan (rituximab) in P-III PEMPHIX Study to Treat Patients with Moderate to Severe Pemphigus Vulgaris

Genentech Reports Positive Results of Rituxan (rituximab) in P-III PEMPHIX Study to Treat Patients with Moderate to Severe Pemphig...

June 13, 2019

Roche's MabThera (rituximab) Receives EU's Approval for Rare Autoimmune Disease Pemphigus Vulgaris (PV)

Roche's MabThera (rituximab) Receives EU's Approval for Rare Autoimmune Disease Pemphigus Vulgaris (PV)

March 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us